Provider-directed marketing may increase prescribing of medications for opioid use disorder-Reference-Cited by-同舟云学术

Provider-directed marketing may increase prescribing of medications for opioid use disorder

Published:2019-09 Issue: Volume:104 Page:104-115
ISSN:0740-5472
Container-title:Journal of Substance Abuse Treatment
language:en
Short-container-title:Journal of Substance Abuse Treatment

Author:

Nguyen Thuy^ORCID,Andraka-Christou Barbara^ORCID,Simon Kosali^ORCID,Bradford W. David^ORCID

Funder

Indiana University

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous),Pshychiatric Mental Health

Reference66 articles.

1. Extended-release naltrexone: A qualitative analysis of barriers to routine use;Alanis-Hirsch;Journal of Substance Abuse Treatment,2016

2. Alderks, C. E. (2017). Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003–2015 (update).

3. A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices;Andraka-Christou;International Journal of Drug Policy,2018

4. Climate classification is an important factor in assessing quality-of-care across hospitals;Boland;Scientific Reports,2017

5. Results from the 2016 National Survey on Drug Use and Health: Detailed tables;Center for Behavioral Health Statistics and Quality,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hiding Behind Complexity: Supply Chain, Oversight, Race, and the Opioid Crisis;Production and Operations Management;2024-04-23

2. Exploring OTC drug consumers’ perception towards online shopping and digital marketing through qualitative interviews: A sample from Malaysia;International Journal of Healthcare Management;2023-01-04

3. Association Between Open Payments–Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US;JAMA Ophthalmology;2022-09-01

4. Promotional Payments to Medical Oncologists and Urologists and Prescriptions for Abiraterone and Enzalutamide;Urology;2021-12

5. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study;Journal of Substance Abuse Treatment;2021-10